ACOR

Acorda Therapeutics
ACOR

Overview Fund Trends Analyst Outlook Journalist POV
Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

151 hedge funds and large institutions have $1B invested in Acorda Therapeutics in 2017 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 74 increasing their positions, 31 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $

less funds holding

Funds holding: →

less first-time investments, than exits

New positions opened: | Existing positions closed:

67% less call options, than puts

Call options by funds: $6.08M | Put options by funds: $18.3M

Holders
151
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$6.08M
Puts
$18.3M
Net Calls
Net Calls Change

Top Buyers

1
+$51M
2
+$32.6M
3
+$16.8M
4
HEC
Hudson Executive Capital
New York
+$15.2M
5
Citadel Advisors
Citadel Advisors
Florida
+$12.1M

Top Sellers

1
-$69.3M
2
-$13M
3
-$11.7M
4
Loomis, Sayles & Company
Loomis, Sayles & Company
Massachusetts
-$10.9M
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$8.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
26
$6.92M
27
$6.67M
28
$6.46M
29
$6.09M
30
$4.84M
31
$4.83M
32
$4.45M
33
$4.38M
34
$4.29M
35
$3.92M
36
$3.57M
37
$3.53M
38
$3.05M
39
$2.4M
40
$2.31M
41
$2.29M
42
$2.17M
43
$2.05M
44
$1.97M
45
$1.82M
46
$1.8M
47
$1.77M
48
$1.75M
49
$1.7M
50
$1.67M
1
2
3 4 5